Consistent with our findings, Song et al. have demonstrated that m6A methyltransferase METTL3 was increased and promoting osteosarcoma cell progression by regulating the m6A level of LEF1 and activating Wnt/β-catenin signaling pathway28. The gene discussed is LEF1; the disease is osteosarcoma.